Enhancing isoprenoid production through systematically assembling and modulating efflux pumps in Escherichia coli

Enhancement of the cellular exportation of heterologous compounds is an important aspect to improve the product yield in microbial cell factory. Efflux pumps can expel various intra- or extra-cellular substances out of microbial hosts and increase the cellular tolerance. Thus in this study, by using the hydrophobic sesquiterpene (amorphadiene) and diterpene (kaurene) as two model compounds, we attempted to improve isoprenoid production through systematically engineering the efflux pumps in Escherichia coli BL21(DE3). The pleiotropic resistant pumps, AcrAB-TolC, MdtEF-TolC from E. coli and heterologous MexAB-OprM pump from Pseudomonas aeruginosa, were overexpressed, assembled, and finely modulated. We found that overexpression of AcrB and TolC components can effectively enhance the specific yield of amorphadiene and kaurene, e.g., 31 and 37 % improvement for amorphadiene compared with control, respectively. The heterologous MexB component can enhance kaurene production with 70 % improvement which is more effective than TolC and AcrB. The results suggest that the three components of tripartite efflux pumps play varied effect to enhance isoprenoid production. Considering the highly organized structure of efflux pumps and importance of components interaction, various component combinations were constructed and the copy number of key components AcrB and TolC was finely modulated as well. The results exhibit that the combination TolC and TolC and AcrB improved the specific yield of amorphadiene with 118 %, and AcrA and TolC and AcrB improved that of kaurene with 104 %. This study indicates that assembling and finely modulating efflux pumps is an effective strategy to improve the production of heterologous compounds in E. coli.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  K. Kobayashi,et al.  Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli , 1997, Applied and environmental microbiology.

[3]  R. Aono.  Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes. , 1998, Extremophiles : life under extreme conditions.

[4]  C. Walsh.  Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.

[5]  C. Calladine,et al.  The role of the TolC family in protein transport and multidrug efflux. From stereochemical certainty to mechanistic hypothesis. , 2001, European journal of biochemistry.

[6]  Christina Cramer,et al.  Antibiotic Susceptibility Profiles ofEscherichia coli Strains Lacking Multidrug Efflux Pump Genes , 2001, Antimicrobial Agents and Chemotherapy.

[7]  E. Bokma,et al.  Interactions underlying assembly of the Escherichia coli AcrAB–TolC multidrug efflux system , 2004, Molecular microbiology.

[8]  H. Zgurskaya,et al.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex* , 2004, Journal of Biological Chemistry.

[9]  K. Poole.  Efflux-mediated antimicrobial resistance. , 2005, The Journal of antimicrobial chemotherapy.

[10]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[11]  Fred C Tenover,et al.  Mechanisms of antimicrobial resistance in bacteria. , 2006, The American journal of medicine.

[12]  Ufuk Hasdemir.  [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria]. , 2007, Mikrobiyoloji bulteni.

[13]  Jay D Keasling,et al.  Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. , 2007, Nature chemical biology.

[14]  P. Bradford,et al.  MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. , 2007, The Journal of antimicrobial chemotherapy.

[15]  T. Riley,et al.  Role of the MexAB-OprM Efflux Pump of Pseudomonas aeruginosa in Tolerance to Tea Tree (Melaleuca alternifolia) Oil and Its Monoterpene Components Terpinen-4-ol, 1,8-Cineole, and α-Terpineol , 2008, Applied and Environmental Microbiology.

[16]  S. Walker,et al.  An ABC transporter encoding gene lndW confers resistance to landomycin E , 2008, Archives of Microbiology.

[17]  H. Zgurskaya,et al.  Kinetic control of TolC recruitment by multidrug efflux complexes , 2009, Proceedings of the National Academy of Sciences.

[18]  Jay D. Keasling,et al.  High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli , 2009, PloS one.

[19]  A. Yamaguchi,et al.  Role of the AraC–XylS family regulator YdeO in multi-drug resistance of Escherichia coli , 2009, The Journal of Antibiotics.

[20]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[21]  Z. Deng,et al.  Overexpression of the ABC transporter AvtAB increases avermectin production in Streptomyces avermitilis , 2011, Applied Microbiology and Biotechnology.

[22]  J. Slonczewski,et al.  A Requirement of TolC and MDR Efflux Pumps for Acid Adaptation and GadAB Induction in Escherichia coli , 2011, PloS one.

[23]  J. Keasling,et al.  Engineering microbial biofuel tolerance and export using efflux pumps , 2011, Molecular systems biology.

[24]  M. Dunlop.  Engineering microbes for tolerance to next-generation biofuels , 2011, Biotechnology for biofuels.

[25]  H. Zgurskaya,et al.  Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. , 2011, Chemistry & biology.

[26]  Hiroshi Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.

[27]  J. Keasling,et al.  Microbial engineering for the production of advanced biofuels , 2012, Nature.

[28]  Eui-Sung Choi,et al.  Enhancement of geraniol resistance of Escherichia coli by MarA overexpression. , 2013, Journal of bioscience and bioengineering.